Cincinnati, OH, United States of America

Ken Kangyi Qian

This inventor holds 10 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 5 EPO patents. Top assignees: Eli Lilly and Company, Adare Pharmaceuticals, Inc., Aptalis Pharmatech, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ken Kangyi Qian. Retrieved from https://idiyas.com/inventor/ken-kangyi-qian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 9)

% Patents Active = 70.0

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 67(Granted Patents)

Location History:

Cincinnati, OH (US) (2013 - 2017)
Manchester, CT (US) (2019 - 2021)
Carmel, IN (US) (2022 - 2024)

Company Filing History:

5 out of 4,514

Eli Lilly and Company

patents

3 out of 30

Adare Pharmaceuticals, Inc.

patents

1 out of 11

Aptalis Pharmatech, Inc.

patents

4. 1 out of 12

Eurand Pharmaceuticals, Ltd.

patents

Years Active: 2013-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12629404 - GIP/GLP1 AGONIST COMPOSITIONS (2026-05-19),

2. 12453756 - GIP/GLP1 agonist compositions (2025-10-28),

3. 12453755 - GIP/GLP1 agonist compositions (2025-10-28),

4. 11918623 - GIP/GLP1 agonist compositions (2024-03-05),

5. 11357820 - GIP/GLP1 agonist compositions (2022-06-14),

6. 10952971 - Taste-masked pharmaceutical compositions with gastrosoluble pore-formers (2021-03-23),

7. 10471017 - Taste-masked pharmaceutical compositions with gastrosoluble pore-formers (2019-11-12),

8. 9730896 - Orally disintegrating tablets and methods of manufacture (2017-08-15),

9. 9089490 - Orally disintegrating tablets and methods of manufacture (2015-07-28),

10. 8545881 - Orally disintegrating tablets and methods of manufacture (2013-10-01),

Title: Ken Kangyi Qian: Innovator in Pharmaceutical Compositions

Introduction: Ken Kangyi Qian is a prominent inventor based in Cincinnati, OH (US), known for his significant contributions to the field of pharmaceutical compositions. He holds a total of 7 patents, showcasing his innovative approach to drug development.

Latest Patents: Among his latest patents is a composition of tirzepatide, which includes an agent selected from NaCl and propylene glycol, as well as dibasic sodium phosphate. This invention highlights his expertise in creating effective GIP/GLP1 agonist compositions.

Career Highlights: Ken has worked with notable companies in the pharmaceutical industry, including Adare Pharmaceuticals, Inc. and Eli Lilly and Company. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.

Collaborations: Throughout his career, Ken has collaborated with esteemed colleagues such as Gopi M Venkatesh and Shyam Vangala. These partnerships have further enhanced his ability to innovate and develop new pharmaceutical solutions.

Conclusion: Ken Kangyi Qian's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.